We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App




New Automated Chemistry Analyzer Presented at IBMS 2015

By LabMedica International staff writers
Posted on 11 Oct 2015
Print article
Caption: The new Altair 240 bench-top clinical chemistry analyzer with LIS bi-directional connectivity fulfills a need for an automated, cost-effective platform supported by the broad menu of Stanbio Chemistry liquid reagents (Photo courtesy of EKF Diagnostics).
Caption: The new Altair 240 bench-top clinical chemistry analyzer with LIS bi-directional connectivity fulfills a need for an automated, cost-effective platform supported by the broad menu of Stanbio Chemistry liquid reagents (Photo courtesy of EKF Diagnostics).
A new clinical chemistry analyzer provides an automated bench-top platform with an integrated chemistry system supported by a broad menu of ready-to-use, bar coded reagents.

EKF Diagnostics (Cardiff, UK) announced the UK launch of its “Altair 240” clinical chemistry analyzer at the Institute of Biomedical Science Congress 2015 (IBMS, September 28-30, 2015; Birmingham, UK). Also highlighted was the latest additions to its range of Stanbio liquid-stable, LiquiColor and Liqui-UV reagents, including an assay for Procalcitonin.

Altair 240 fulfills a need for an automated, cost-effective bench-top platform supported by the reliable Stanbio Chemistry liquid reagent menu for routine and special chemistries. Altair 240 also provides the flexibility to configure open-channel applications for many esoteric assays. Built on 54 years of expertise, the system with LIS bi-directional connectivity is easy-to-use, as either a main or back-up analyzer, and is capable of performing up to 480 tests/hour (double-arm functionality yields up to 480 tests/hour).

Also presented at IBMS 2015 was the Stanbio Chemistry - Procalcitonin (PCT) LiquiColor Assay, a new rapid test enabling the quantitative determination of PCT in serum samples, EDTA, or lithium heparin plasma samples by latex-enhanced immunoturbidimetric methodology. PCT is a marker for bacterial infection and sepsis and has been recognized as an important adjunct marker in the diagnosis of sepsis. The test provides a precise result that correlates well with established methodology, within 10 minutes and requires only 20 µL of sample. The reagents may be used on almost any liquid-based chemistry analyzer with open-channel capability. Reagent kit, calibrator, and control sets are available separately.

Other products showcased at EKF’s IBMS booth included: B-Hydroxybutyrate (B-HB) LiquiColor Assay for ketosis testing; Glycated Serum Protein (GSP) LiquiColor Assay – a 2-3 week indicator of average blood glucose; Quo-Lab and Quo-Test devices for HbA1c measurement; and Hemo Control hemoglobin analyzer.

Related Links:

EKF Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.